<?xml version="1.0" encoding="UTF-8" standalone="no"?><information><Cell><NavigationPath><Head00>Response</Head00><Stub><StubValue>Complete response</StubValue></Stub><HeaderValue>Small-cell carcinoma (%)</HeaderValue></NavigationPath><value>(18)</value><CellType>Partially Numeric</CellType></Cell><Table><TableType>Matrix</TableType><tableName>Tumour responses according to histologic type (N=56)</tableName><tableOrder>Table 5</tableOrder><tableFooter/></Table><Document><DocumentTitle>Phase I/II trial of weekly cisplatin, etoposide, and irinotecan chemotherapy for metastatic lung cancer: JCOG 9507</DocumentTitle><PMC>2377075</PMC></Document></information>